Atrial Fibrillation (AF) is a prevalent heart rhythm disorder characterized by irregular and often rapid heartbeats. In this condition, the heart's upper chambers (atria) quiver or flutter, disrupting the normal electrical impulses that coordinate heartbeats. As a result, the heart may not pump blood effectively, leading to potential complications such as blood clots, stroke, or heart failure. AF can affect individuals of any age, but it becomes more common with age, and certain factors such as hypertension, diabetes, and heart disease can elevate the risk. Symptoms may include palpitations, fatigue, dizziness, and shortness of breath. Timely diagnosis and management of Atrial Fibrillation are crucial to mitigate associated risks and enhance the quality of life for those affected. Treatment strategies often involve medications, lifestyle modifications, and in some cases, medical procedures to restore or regulate the heart's rhythm. As research continues to advance, a better understanding of the mechanisms behind AF and innovative treatment options offer hope for improved outcomes and enhanced patient care
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain